Seneca provides further support to Optibiotix
A York life sciences business developing products to tackle obesity, high cholesterol and diabetes has raised £1m of funding in a placing which has led to Seneca Partners increasing its stake. Stephen O’Hara, chief executive of OptiBiotix, said: “We are…